Daniel Bradbury

Independent Director

Professional Experience
  • Executive Chairman, former CEO and Co-Founder, Equillium Inc.
  • Managing Member, BioBrit LLC
  • Member, Board of Trustees, Keck Graduate Institute, USA
  • Director, Intercept Pharmaceuticals and several private companies and philanthropic organizations
  • Board Chairman, Castle Biosciences Inc. and Biolinq
  • Member, Advisory Council, Rady School of Management, San Diego, USA
  • Former CEO, Amylin Pharmaceuticals (acquired by Bristol Myers Squibb in 2012)
  • Life sciences executive with 38+ years of experience in creating and implementing strategies and transforming businesses
Recognition
  • Director of the Year Award from Corporate Directors Forum (2012)
  • EY Entrepreneur of the Year Finalist (2012)
Education
  • International Executive Program, INSEAD, France
  • Diploma in Management Studies, Harrow and Ealing Colleges of Higher Education, UK
  • BPharm, Nottingham University, UK
Download PDF
Related Links

Manufacturing

We have built global scale and world-class capabilities that leverage advanced technologies and an unwavering commitment to quality, to transform...
Read More

Monoclonal Antibodies

Biocon Biologics has a proven track record in the science, scale, scope and complexity of biologics manufacturing. Over the years...
Read More

Connect with us

Subscribe

Our Parent Company

Quick Links

Our Parent Company
Facebook-f Youtube Linkedin-in

© 2025, Biocon Biologics Limited (a Subsidiary of Biocon Limited). All Rights Reserved

Leaving the Biocon Biologics Corporate Website

You are now leaving the Biocon Biologics Corporate website for a Biocon Biologics EU Corporate microsite that is solely responsible for its content, including its compliance with guidelines applicable in certain geographies. Links to Biocon Biologics affiliate sites are provided as a resource to our visitors and may not be governed by the same regulatory requirements applicable to this site and unaffiliated third party sites are subject to their own terms and data protection notices and practices. Moreover, if their third party site is subject to other country laws, regulatory requirements, data protection requirements or medical practices may differ between countries and the information provided therein may not be suitable for use in your country.

Agree

Leaving the Biocon Biologics Corporate Website

You are now leaving the Biocon Biologics Corporate website for a Biocon Biologics U.S. Corporate microsite that is solely responsible for its content, including its compliance with guidelines applicable in certain geographies. Links to Biocon Biologics affiliate sites are provided as a resource to our visitors and may not be governed by the same regulatory requirements applicable to this site and unaffiliated third party sites are subject to their own terms and data protection notices and practices. Moreover, if their third party site is subject to other country laws, regulatory requirements, data protection requirements or medical practices may differ between countries and the information provided therein may not be suitable for use in your country.

Agree

Leaving the Biocon Biologics site

You are now leaving the Biocon Biologics page for a Biocon Biologics affiliate site or third party site that is solely responsible for its content, including its compliance with guidelines applicable in certain geographies. Links to Biocon Biologics affiliate sites and third party sites are provided as a resource to our visitors and may not be governed by the same regulatory requirements applicable to this site and unaffiliated third party sites are subject to their own terms and data protection notices and practices. Moreover, if their third party site is subject to other country laws, regulatory requirements, data protection requirements or medical practices may differ between countries and the information provided therein may not be suitable for use in your country.

Agree